Independent global media advisor MediaSense, has acquired R3, the creative and media advisory for an undisclosed amount, to ...

In 2004, The Novartis Institute for Tropical Disease opened in Singapore, with a focus on biomedical research for dengue fever and drug-resistant tuberculosis. The company also acquired two ...

The reacquisition of the full global commercial rights to ociperlimab and TEVIMBRA in the third quarter of 2023 resulted in ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical manufacturing capabilities and talent base ...

Multinational medical companies reached collaborations with local healthcare authorities, hospitals and businesses at the ongoing 7th China International Import Expo held in Shanghai to jointly build ...

Returns represent past performance and do not guarantee future results. Investment return and share price will fluctuate with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Thanks for subscribing! Look out for your first newsletter in your inbox soon! The best of Singapore for free. Sign up for our email to enjoy Singapore without spending a thing (as well as some ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 2,666.61 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...